Darnytsia Receives Lithuania’s GMP Certificate: The Quality of Ukrainian Medicines Recognized by Europe

Darnytsia Pharmaceutical Company has once again proven that Ukrainian medicines can be not only high-quality, effective, and safe, but also meet the strictest European standards.

After a thorough inspection by the Lithuanian State Medicines Control Agency, Darnytsia received the GMP certificate—a “green light” for exporting its products to Lithuania and other strictly regulated countries where Darnytsia’s medicines are registered.

Obtaining the certificate was preceded by a meticulous inspection by Lithuanian experts of the ampoule production facility, the infusion solutions area, and the solid dosage forms workshop. Darnytsia confidently passed all stages of the inspection and now holds Lithuania’s GMP certificate.

“Entering new markets is not just an ambitious goal, but a daily reality for Darnytsia. The Lithuanian GMP certificate is yet another international recognition of the quality of our products. We have proven that Ukrainian medicines can meet the highest European standards and confidently compete with foreign brands. For us, this is not only new export opportunities, but also a source of pride for Ukrainian pharmaceuticals,” emphasizes Hurhen Karapetian, Export & Hospital Sales Director at Darnytsia.

“The production processes at Darnytsia comply with the most advanced international requirements. Our technologies and equipment are on par with those of leading global manufacturers, and our raw materials are only the best—tested and certified. We implement the same standards as global pharmaceutical companies, which allows us to create medicines trusted not only in Ukraine, but also in Europe,” highlights Olha Kramarenko, Quality Director at Darnytsia.

Obtaining Lithuania’s GMP certificate is yet another confirmation that Darnytsia is a modern company producing effective, safe, and internationally competitive medicines.